Open

Study of AUTX-007 for Leukemia

The purpose of the study is to find out is AUTX-007 an investigational drug, can help treat or cure cancer.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

As apraticpant, here is what to expect: -You will have blood work and vital signs taken -You will have a bone marrow biopsy -You will have a physical exam -You will complete questionnaires

Incentives

In-person visits:
15+

Total length of participation:
24

Looking for Specific Volunteers

Able to participate:

Diagnosis of Leukemia
Adequate liver function
Good cardiac function

Not eligible if:

Had previous Chemotherapy within the last 60 days
Condition requires systemic steroid therapy
Taking a proton pump inhibitor
Leukemia affecting the central nervous system
Severe active infection

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Lineberger Comprehensive Cancer Center
cancerclinicaltrials@med.unc.edu
(919) 966-4432

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Joshua Zeidner
Medicine-Hematology

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Leukemia)

IRB Number

25-0446

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.